Takeda Pharmaceutical (TYO:4502) has been on a partnership spree lately, inking at least 65 collaborations and deal in the last 18 months.
Fueling those agreements is a fundamental belief that to reinvigorate the pharmaceutical industry, access to innovative science is crucial, according to Daniel Curran, SVP & head of the Japan-based company’s Center for External Innovation.
Get the full story at our sister site, Drug Delivery Business News.
The post Why Takeda thinks partnerships can revive innovation in pharma appeared first on MassDevice.